{"users":[{"id":4,"username":"Naiffer_Host","name":"Naiffer Romero","avatar_template":"/user_avatar/nitrosamines.usp.org/naiffer_host/{size}/3608_2.png","flair_name":"USP_Staff","flair_url":"/uploads/db7259/original/1X/340334bffe0860cc90b26df2ade9e5becac890a9.png","flair_group_id":42,"admin":true,"moderator":true,"trust_level":2},{"id":184,"username":"kpcross","name":"Kevin P Cross","avatar_template":"/user_avatar/nitrosamines.usp.org/kpcross/{size}/221_2.png","trust_level":1},{"id":2,"username":"RichardMillington","name":"Richard Millington","avatar_template":"/user_avatar/nitrosamines.usp.org/richardmillington/{size}/7_2.png","primary_group_name":"USP_Volunteers","flair_name":"USP_Volunteers","flair_url":"/uploads/db7259/original/1X/afe0aa961ce60b1e331391ce15295fe50cf9c041.png","flair_group_id":43,"admin":true,"moderator":true,"trust_level":2},{"id":695,"username":"Georg_Ever2018","name":"Georg Pour","avatar_template":"/letter_avatar_proxy/v4/letter/g/898d66/{size}.png","trust_level":2},{"id":1287,"username":"VENKATESAN.G","name":"VENKATESAN G","avatar_template":"/letter_avatar_proxy/v4/letter/v/e36b37/{size}.png","trust_level":2},{"id":3653,"username":"Dileep5571","name":"Dileep","avatar_template":"/letter_avatar_proxy/v4/letter/d/d07c76/{size}.png","trust_level":1},{"id":8148,"username":"Renata77","name":"Renata Camardella","avatar_template":"/user_avatar/nitrosamines.usp.org/renata77/{size}/4059_2.png","primary_group_name":"Brazil_Community","flair_name":"Brazil_Community","flair_url":"/uploads/db7259/original/2X/6/675492472493cf415afcac19a24036aae652b958.png","flair_group_id":63,"trust_level":1},{"id":8711,"username":"Resh_18","name":"Reshma Mukherjee","avatar_template":"/letter_avatar_proxy/v4/letter/r/e9c0ed/{size}.png","trust_level":1},{"id":3470,"username":"Iyappan","name":"Iyappan","avatar_template":"/letter_avatar_proxy/v4/letter/i/bbce88/{size}.png","trust_level":2},{"id":146,"username":"jason.brown","name":"Jason Brown","avatar_template":"/user_avatar/nitrosamines.usp.org/jason.brown/{size}/4272_2.png","trust_level":2},{"id":14,"username":"ASrinivasan","name":"Aloka Srinivasan","avatar_template":"/letter_avatar_proxy/v4/letter/a/b4bc9f/{size}.png","trust_level":2},{"id":3469,"username":"elenipoliti","name":"Eleni","avatar_template":"/user_avatar/nitrosamines.usp.org/elenipoliti/{size}/3654_2.png","trust_level":2},{"id":133,"username":"Yosukemino","name":"Yosuke Mino","avatar_template":"/user_avatar/nitrosamines.usp.org/yosukemino/{size}/187_2.png","trust_level":2},{"id":3250,"username":"vinod.thorat","name":"Dr. Vinod Thoart","avatar_template":"/user_avatar/nitrosamines.usp.org/vinod.thorat/{size}/1333_2.png","trust_level":2},{"id":1436,"username":"Amy","name":"Amy","avatar_template":"/letter_avatar_proxy/v4/letter/a/4da419/{size}.png","trust_level":1},{"id":20,"username":"fernandaw","name":"Fernanda","avatar_template":"/user_avatar/nitrosamines.usp.org/fernandaw/{size}/1984_2.png","primary_group_name":"Brazil_Community","flair_name":"Brazil_Community","flair_url":"/uploads/db7259/original/2X/6/675492472493cf415afcac19a24036aae652b958.png","flair_group_id":63,"trust_level":2},{"id":6301,"username":"gghalder2512","name":"Gautam Halder","avatar_template":"/letter_avatar_proxy/v4/letter/g/41988e/{size}.png","trust_level":2},{"id":52,"username":"JavierFernandez","name":"","avatar_template":"/letter_avatar_proxy/v4/letter/j/9de053/{size}.png","trust_level":2},{"id":3295,"username":"MTwohig","name":"Marian Twohig","avatar_template":"/letter_avatar_proxy/v4/letter/m/df705f/{size}.png","trust_level":1},{"id":7927,"username":"mayrlaache","name":"Mayrla Vasconcelos","avatar_template":"/user_avatar/nitrosamines.usp.org/mayrlaache/{size}/4222_2.png","primary_group_name":"Brazil_Community","flair_name":"Brazil_Community","flair_url":"/uploads/db7259/original/2X/6/675492472493cf415afcac19a24036aae652b958.png","flair_group_id":63,"trust_level":2},{"id":5355,"username":"dcobice","name":"Diego Cobice","avatar_template":"/letter_avatar_proxy/v4/letter/d/35a633/{size}.png","trust_level":2},{"id":6903,"username":"Hasan_T","name":"Hasan Tünel","avatar_template":"/letter_avatar_proxy/v4/letter/h/edb3f5/{size}.png","trust_level":2},{"id":6244,"username":"JoaoGerheim","name":"","avatar_template":"/user_avatar/nitrosamines.usp.org/joaogerheim/{size}/4072_2.png","primary_group_name":"Brazil_Community","flair_name":"USP_Risk_Assessment","flair_url":"comment-dots","flair_group_id":71,"trust_level":2},{"id":6650,"username":"Venki","name":"Venkiteswaran Krishnan","avatar_template":"/letter_avatar_proxy/v4/letter/v/f0a364/{size}.png","trust_level":1},{"id":8120,"username":"accarter92","name":"Adam Carter","avatar_template":"/letter_avatar_proxy/v4/letter/a/cab0a1/{size}.png","trust_level":1},{"id":153,"username":"Diego_HM","name":"Diego Hermosa Martinez","avatar_template":"/letter_avatar_proxy/v4/letter/d/7bcc69/{size}.png","trust_level":2},{"id":6537,"username":"mvinas","name":"Miquel","avatar_template":"/letter_avatar_proxy/v4/letter/m/76d3ee/{size}.png","trust_level":2},{"id":502,"username":"IreneNS","name":"Irene Navarro","avatar_template":"/user_avatar/nitrosamines.usp.org/irenens/{size}/1645_2.png","trust_level":2},{"id":1020,"username":"hgajjar","name":"Haresh","avatar_template":"/letter_avatar_proxy/v4/letter/h/4da419/{size}.png","trust_level":2},{"id":7660,"username":"zifeng.zhu","name":"zifeng zhu","avatar_template":"/letter_avatar_proxy/v4/letter/z/d9b06d/{size}.png","trust_level":1},{"id":7134,"username":"dineli.ranathunga","name":"Dineli Ranathunga","avatar_template":"/letter_avatar_proxy/v4/letter/d/3d9bf3/{size}.png","trust_level":1},{"id":6483,"username":"andrew003","name":"Baifeng An","avatar_template":"/letter_avatar_proxy/v4/letter/a/ba9def/{size}.png","trust_level":1},{"id":3290,"username":"Sagar","name":"Sagar","avatar_template":"/letter_avatar_proxy/v4/letter/s/6de8d8/{size}.png","trust_level":2},{"id":3790,"username":"Beltran","name":"Thierry","avatar_template":"/letter_avatar_proxy/v4/letter/b/f19dbf/{size}.png","trust_level":1},{"id":4646,"username":"Vinay.Mamidala","name":"Vinay","avatar_template":"/letter_avatar_proxy/v4/letter/v/b782af/{size}.png","trust_level":1},{"id":4802,"username":"chrischar","name":"christos","avatar_template":"/letter_avatar_proxy/v4/letter/c/c4cdca/{size}.png","trust_level":2},{"id":6705,"username":"heba-1994","name":"heba ","avatar_template":"/letter_avatar_proxy/v4/letter/h/f4b2a3/{size}.png","trust_level":1},{"id":2485,"username":"mflorea","name":"Mircea Florea","avatar_template":"/letter_avatar_proxy/v4/letter/m/eb9ed0/{size}.png","trust_level":2},{"id":1326,"username":"Yuvraj","name":"Yuvraj Marne","avatar_template":"/user_avatar/nitrosamines.usp.org/yuvraj/{size}/1510_2.png","flair_name":"USP_Risk_Assessment","flair_url":"comment-dots","flair_group_id":71,"trust_level":2},{"id":5080,"username":"anonymous64","name":"anonymous64","avatar_template":"/letter_avatar_proxy/v4/letter/a/b19c9b/{size}.png","trust_level":1},{"id":1243,"username":"Rafa","name":"","avatar_template":"/letter_avatar_proxy/v4/letter/r/e495f1/{size}.png","trust_level":2},{"id":2779,"username":"MarkS","name":"","avatar_template":"/user_avatar/nitrosamines.usp.org/marks/{size}/2220_2.png","trust_level":2},{"id":3368,"username":"ccdw","name":"C. Wybon","avatar_template":"/letter_avatar_proxy/v4/letter/c/d9b06d/{size}.png","trust_level":2},{"id":256,"username":"DanitaBroyles","name":"Danita Broyles","avatar_template":"/user_avatar/nitrosamines.usp.org/danitabroyles/{size}/200_2.png","trust_level":2},{"id":2996,"username":"Vamshi","name":"Vamshikrishna ","avatar_template":"/letter_avatar_proxy/v4/letter/v/ecccb3/{size}.png","trust_level":1},{"id":5557,"username":"lling","name":"","avatar_template":"/letter_avatar_proxy/v4/letter/l/ba8739/{size}.png","trust_level":1},{"id":2844,"username":"Jaume_Tomas","name":"Jaume Tomas","avatar_template":"/user_avatar/nitrosamines.usp.org/jaume_tomas/{size}/3191_2.png","trust_level":2},{"id":16,"username":"conudel","name":"Raphael Nudelman","avatar_template":"/user_avatar/nitrosamines.usp.org/conudel/{size}/803_2.png","primary_group_name":"Founding_Expert","flair_name":"Founding_Expert","flair_url":"/uploads/db7259/original/1X/ed130d5eb79ecba59b1f56070c0d9e143c1f652e.png","flair_group_id":45,"trust_level":2},{"id":2532,"username":"paliog","name":"Giovanni Palio","avatar_template":"/user_avatar/nitrosamines.usp.org/paliog/{size}/1187_2.png","trust_level":2},{"id":5107,"username":"Raza","name":"Mohammed Raza","avatar_template":"/letter_avatar_proxy/v4/letter/r/82dd89/{size}.png","trust_level":1},{"id":4027,"username":"jasmin","name":"Jasmin","avatar_template":"/letter_avatar_proxy/v4/letter/j/9de053/{size}.png","trust_level":2},{"id":2480,"username":"Alaaelkazak","name":"Alaa","avatar_template":"/letter_avatar_proxy/v4/letter/a/8491ac/{size}.png","trust_level":2},{"id":6634,"username":"Bojana","name":"Bojana Vulovska Trifunovska","avatar_template":"/letter_avatar_proxy/v4/letter/b/6bbea6/{size}.png","trust_level":2},{"id":5702,"username":"Hermine4011","name":"Hermine Takhtalyan","avatar_template":"/user_avatar/nitrosamines.usp.org/hermine4011/{size}/4044_2.png","trust_level":2}],"primary_groups":[{"id":43,"name":"USP_Volunteers"},{"id":63,"name":"Brazil_Community"},{"id":45,"name":"Founding_Expert"}],"flair_groups":[{"id":42,"name":"USP_Staff","flair_url":"/uploads/db7259/original/1X/340334bffe0860cc90b26df2ade9e5becac890a9.png","flair_bg_color":"","flair_color":""},{"id":43,"name":"USP_Volunteers","flair_url":"/uploads/db7259/original/1X/afe0aa961ce60b1e331391ce15295fe50cf9c041.png","flair_bg_color":"","flair_color":""},{"id":63,"name":"Brazil_Community","flair_url":"/uploads/db7259/original/2X/6/675492472493cf415afcac19a24036aae652b958.png","flair_bg_color":"","flair_color":""},{"id":71,"name":"USP_Risk_Assessment","flair_url":"comment-dots","flair_bg_color":"","flair_color":""},{"id":45,"name":"Founding_Expert","flair_url":"/uploads/db7259/original/1X/ed130d5eb79ecba59b1f56070c0d9e143c1f652e.png","flair_bg_color":"","flair_color":""}],"topic_list":{"can_create_topic":false,"more_topics_url":"/c/riskmitigation/16?page=1","per_page":30,"top_tags":[{"id":12,"name":"NDSRI","slug":"ndsri"},{"id":6,"name":"Drug_Substance_APIs","slug":"drug-substance-apis"},{"id":23,"name":"risk-assessment","slug":"risk-assessment"},{"id":2,"name":"Excipients","slug":"excipients"},{"id":1,"name":"featured","slug":"featured"},{"id":3,"name":"Manufacturing","slug":"manufacturing"},{"id":5,"name":"Packaging","slug":"packaging"},{"id":30,"name":"QSAR","slug":"qsar"},{"id":43,"name":"nap-test","slug":"nap-test"},{"id":59,"name":"purge","slug":"purge"}],"topics":[{"fancy_title":"Carcinogenic Potency Database - Access free","fancy_title_localized":false,"locale":null,"id":3014,"title":"Carcinogenic Potency Database - Access free","slug":"carcinogenic-potency-database-access-free","posts_count":3,"reply_count":0,"highest_post_number":3,"image_url":"https://nitrosamines.usp.org/uploads/db7259/original/1X/17e7c1a431ef1187b3d72168baeb4201c062e0b1.png","created_at":"2022-07-06T13:52:25.041Z","last_posted_at":"2022-07-13T13:37:36.736Z","bumped":true,"bumped_at":"2022-07-13T13:37:36.736Z","archetype":"regular","unseen":false,"pinned":true,"unpinned":null,"excerpt":"With discussions about limits and how they are establish, it’s an important reminder about the Carcinogenic Potency Database, now The Lhasa Carcinogenicity Database (LCDB). \nBelow from Lhasa article: “5 things you should…","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":[{"max_width":null,"max_height":null,"width":309,"height":337,"url":"https://nitrosamines.usp.org/uploads/db7259/original/1X/17e7c1a431ef1187b3d72168baeb4201c062e0b1.png"}],"tags":[],"tags_descriptions":{},"views":2566,"like_count":7,"has_summary":false,"last_poster_username":"Naiffer_Host","category_id":16,"op_like_count":6,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":"latest","description":"Original Poster, Most Recent Poster","user_id":4,"primary_group_id":null,"flair_group_id":42},{"extras":null,"description":"Recent Poster","user_id":184,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"About the Risk Assessment Strategy / Tools & Technology category","fancy_title_localized":false,"locale":null,"id":36,"title":"About the Risk Assessment Strategy / Tools & Technology category","slug":"about-the-risk-assessment-strategy-tools-technology-category","posts_count":1,"reply_count":0,"highest_post_number":1,"image_url":null,"created_at":"2021-04-14T08:04:37.846Z","last_posted_at":null,"bumped":true,"bumped_at":"2021-04-14T18:01:09.434Z","archetype":"regular","unseen":false,"pinned":true,"unpinned":null,"excerpt":"Discuss about Risk Assessment Strategies and Tools. \nA risk assessment should be conducted to determine the materials that contribute to the potential for inclusion of Nitrosamines in the drug product. All potential sour…","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":null,"tags":[],"tags_descriptions":{},"views":671,"like_count":0,"has_summary":false,"last_poster_username":"RichardMillington","category_id":16,"op_like_count":0,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":"latest single","description":"Original Poster, Most Recent Poster","user_id":2,"primary_group_id":43,"flair_group_id":43}]},{"fancy_title":"Call to review USP Risk Assessment Review Toolbox","fancy_title_localized":false,"locale":null,"id":10216,"title":"Call to review USP Risk Assessment Review Toolbox","slug":"call-to-review-usp-risk-assessment-review-toolbox","posts_count":128,"reply_count":12,"highest_post_number":131,"image_url":"https://nitrosamines.usp.org/uploads/db7259/original/2X/f/feb605d7e65d2dfce8ced9d51a56fc5ec4e81708.jpeg","created_at":"2024-06-06T13:19:10.014Z","last_posted_at":"2026-10-02T14:01:17.082Z","bumped":true,"bumped_at":"2026-10-02T14:01:17.082Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"Greeting Nitrosamines Warriors! @trust_user_a @trust_user_b @trust_user_c @trust_user_d \n:man_scientist: USP’s Nitrosamine Team has been developing a simple tool to assist with the Nitrosamine Risk Assessment. We are rea…","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":[{"max_width":null,"max_height":null,"width":1024,"height":1022,"url":"https://nitrosamines.usp.org/uploads/db7259/original/2X/f/feb605d7e65d2dfce8ced9d51a56fc5ec4e81708.jpeg"},{"max_width":750,"max_height":750,"width":750,"height":748,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/f/feb605d7e65d2dfce8ced9d51a56fc5ec4e81708_2_750x748.jpeg"},{"max_width":500,"max_height":500,"width":500,"height":499,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/f/feb605d7e65d2dfce8ced9d51a56fc5ec4e81708_2_500x499.jpeg"},{"max_width":375,"max_height":375,"width":375,"height":374,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/f/feb605d7e65d2dfce8ced9d51a56fc5ec4e81708_2_375x374.jpeg"}],"tags":[],"tags_descriptions":{},"views":4286,"like_count":43,"has_summary":true,"last_poster_username":"Renata77","category_id":16,"op_like_count":20,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":null,"description":"Original Poster","user_id":4,"primary_group_id":null,"flair_group_id":42},{"extras":null,"description":"Frequent Poster","user_id":695,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":1287,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":3653,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":8148,"primary_group_id":63,"flair_group_id":63}]},{"fancy_title":"Theoretical evaluation of NDSRIs","fancy_title_localized":false,"locale":null,"id":15721,"title":"Theoretical evaluation of NDSRIs","slug":"theoretical-evaluation-of-ndsris","posts_count":14,"reply_count":10,"highest_post_number":14,"image_url":null,"created_at":"2026-08-18T06:38:29.338Z","last_posted_at":"2026-09-25T06:08:50.645Z","bumped":true,"bumped_at":"2026-09-25T06:08:50.645Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"Is a theoretical evaluation of NDSRIs acceptable for a drug product when the impurity is not listed on any health authority website, but its acceptable intake (AI) has been established via the Carcinogenic Potency Catego…","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":null,"tags":[{"id":12,"name":"NDSRI","slug":"ndsri"},{"id":6,"name":"Drug_Substance_APIs","slug":"drug-substance-apis"}],"tags_descriptions":{},"views":655,"like_count":36,"has_summary":false,"last_poster_username":"elenipoliti","category_id":16,"op_like_count":0,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":null,"description":"Original Poster","user_id":8711,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":3470,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":146,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":14,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":3469,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"From Detection to Prediction: AI-driven Process Analytical Technology for Nitrosamine and NDSRI Control in Pharmaceuticals-Pub","fancy_title_localized":false,"locale":null,"id":15725,"title":"From Detection to Prediction: AI-driven Process Analytical Technology for Nitrosamine and NDSRI Control in Pharmaceuticals-Pub","slug":"from-detection-to-prediction-ai-driven-process-analytical-technology-for-nitrosamine-and-ndsri-control-in-pharmaceuticals-pub","posts_count":1,"reply_count":0,"highest_post_number":1,"image_url":"https://nitrosamines.usp.org/uploads/db7259/original/2X/2/2e521271f6010b66497134b20bb360c046068828.png","created_at":"2026-08-19T14:50:50.379Z","last_posted_at":"2026-08-19T14:50:50.602Z","bumped":true,"bumped_at":"2026-08-19T14:50:50.602Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"Abstract\nThe emergence of nitrosamine impurities in widely used medications including sartans, ranitidine, metformin, and rifampicin has triggered global safety concerns, leading to extensive product recalls and rigoro…","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":[{"max_width":null,"max_height":null,"width":685,"height":376,"url":"https://nitrosamines.usp.org/uploads/db7259/original/2X/2/2e521271f6010b66497134b20bb360c046068828.png"},{"max_width":500,"max_height":500,"width":500,"height":274,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/2/2e521271f6010b66497134b20bb360c046068828_2_500x274.png"},{"max_width":375,"max_height":375,"width":375,"height":205,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/2/2e521271f6010b66497134b20bb360c046068828_2_375x205.png"}],"tags":[{"id":12,"name":"NDSRI","slug":"ndsri"}],"tags_descriptions":{},"views":174,"like_count":1,"has_summary":false,"last_poster_username":"Yosukemino","category_id":16,"op_like_count":1,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":"latest single","description":"Original Poster, Most Recent Poster","user_id":133,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"QSAR Toolbox - Free software. Any experience?","fancy_title_localized":false,"locale":null,"id":3467,"title":"QSAR Toolbox - Free software. Any experience?","slug":"qsar-toolbox-free-software-any-experience","posts_count":23,"reply_count":11,"highest_post_number":24,"image_url":"https://nitrosamines.usp.org/uploads/db7259/optimized/1X/66a0c16272e591133ea79e0ee5b9e0421c47c8cd_2_1024x576.jpeg","created_at":"2022-08-25T14:40:18.126Z","last_posted_at":"2026-07-31T04:07:36.597Z","bumped":true,"bumped_at":"2026-07-31T04:07:36.597Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"Do you know the QSAR Toolbox? \nThe OECD QSAR Toolbox is a software designed to support hazard assessment of chemicals as well as to increase mechanistic and other knowledge on chemical substances in a cost-efficient way.…","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":[{"max_width":null,"max_height":null,"width":1600,"height":900,"url":"https://nitrosamines.usp.org/uploads/db7259/original/1X/66a0c16272e591133ea79e0ee5b9e0421c47c8cd.jpeg"},{"max_width":1024,"max_height":1024,"width":1024,"height":576,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/1X/66a0c16272e591133ea79e0ee5b9e0421c47c8cd_2_1024x576.jpeg"},{"max_width":750,"max_height":750,"width":750,"height":421,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/1X/66a0c16272e591133ea79e0ee5b9e0421c47c8cd_2_750x421.jpeg"},{"max_width":500,"max_height":500,"width":500,"height":281,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/1X/66a0c16272e591133ea79e0ee5b9e0421c47c8cd_2_500x281.jpeg"},{"max_width":375,"max_height":375,"width":375,"height":210,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/1X/66a0c16272e591133ea79e0ee5b9e0421c47c8cd_2_375x210.jpeg"}],"tags":[],"tags_descriptions":{},"views":2717,"like_count":35,"has_summary":false,"last_poster_username":"gghalder2512","category_id":16,"op_like_count":5,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":null,"description":"Original Poster","user_id":4,"primary_group_id":null,"flair_group_id":42},{"extras":null,"description":"Frequent Poster","user_id":3250,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":1436,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":20,"primary_group_id":63,"flair_group_id":63},{"extras":"latest","description":"Most Recent Poster","user_id":6301,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"Integrating nitrosamine theoretical formation into Translational Pharmaceutics: Mitigating risks during accelerated formulation development in early phase clinical studies-Pub","fancy_title_localized":false,"locale":null,"id":15655,"title":"Integrating nitrosamine theoretical formation into Translational Pharmaceutics: Mitigating risks during accelerated formulation development in early phase clinical studies-Pub","slug":"integrating-nitrosamine-theoretical-formation-into-translational-pharmaceutics-mitigating-risks-during-accelerated-formulation-development-in-early-phase-clinical-studies-pub","posts_count":1,"reply_count":0,"highest_post_number":1,"image_url":null,"created_at":"2026-07-28T16:48:58.411Z","last_posted_at":"2026-07-28T16:48:58.501Z","bumped":true,"bumped_at":"2026-07-28T16:48:58.501Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"https://www.sciencedirect.com/science/article/abs/pii/S0022354926002832 \nAbstract\nNitrosamine impurities, owing to their established carcinogenic potential, represent a significant challenge in contemporary pharmaceutica…","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":null,"tags":[{"id":23,"name":"risk-assessment","slug":"risk-assessment"}],"tags_descriptions":{},"views":145,"like_count":5,"has_summary":false,"last_poster_username":"Yosukemino","category_id":16,"op_like_count":5,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":"latest single","description":"Original Poster, Most Recent Poster","user_id":133,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"Less than daily administration","fancy_title_localized":false,"locale":null,"id":15592,"title":"Less than daily administration","slug":"less-than-daily-administration","posts_count":8,"reply_count":2,"highest_post_number":8,"image_url":null,"created_at":"2026-07-07T13:36:09.832Z","last_posted_at":"2026-07-19T10:42:37.862Z","bumped":true,"bumped_at":"2026-07-19T10:42:37.862Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"Anyone have experience with drugs that are administered monthly, etc.? In these cases, the MDD would be less relevant given the cumulative effect. \nThanks, Jason","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":null,"tags":[],"tags_descriptions":{},"views":506,"like_count":17,"has_summary":false,"last_poster_username":"jason.brown","category_id":16,"op_like_count":1,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":"latest","description":"Original Poster, Most Recent Poster","user_id":146,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":4,"primary_group_id":null,"flair_group_id":42},{"extras":null,"description":"Frequent Poster","user_id":52,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":3295,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":7927,"primary_group_id":63,"flair_group_id":63}]},{"fancy_title":"Nitrosamine risk assessment in early clinical development","fancy_title_localized":false,"locale":null,"id":15550,"title":"Nitrosamine risk assessment in early clinical development","slug":"nitrosamine-risk-assessment-in-early-clinical-development","posts_count":1,"reply_count":0,"highest_post_number":1,"image_url":null,"created_at":"2026-06-17T22:11:04.165Z","last_posted_at":"2026-06-17T22:11:04.270Z","bumped":true,"bumped_at":"2026-06-17T22:11:04.270Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"Dear Nitrosamine Exchange Community, \nI would appreciate any experience or feedback regarding regulatory expectations for nitrosamine risk assessments in Phase I short-term clinical pharmacology studies (e.g., SAD/MAD tr…","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":null,"tags":[],"tags_descriptions":{},"views":230,"like_count":2,"has_summary":false,"last_poster_username":"dcobice","category_id":16,"op_like_count":2,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":"latest single","description":"Original Poster, Most Recent Poster","user_id":5355,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"Removal of nitrosamine analysis from the specification","fancy_title_localized":false,"locale":null,"id":15382,"title":"Removal of nitrosamine analysis from the specification","slug":"removal-of-nitrosamine-analysis-from-the-specification","posts_count":4,"reply_count":1,"highest_post_number":4,"image_url":null,"created_at":"2026-04-21T10:52:27.391Z","last_posted_at":"2026-04-24T00:27:25.931Z","bumped":true,"bumped_at":"2026-04-24T00:27:25.931Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"Hello Everyone, \nI am seeking clarification on the conditions under which nitrosamine analysis can be omitted from product specifications. For instance, API suppliers state that since “nitrosamine analysis was performed …","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":null,"tags":[],"tags_descriptions":{},"views":341,"like_count":10,"has_summary":false,"last_poster_username":"jason.brown","category_id":16,"op_like_count":0,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":null,"description":"Original Poster","user_id":6903,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":3469,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":6244,"primary_group_id":63,"flair_group_id":71},{"extras":"latest","description":"Most Recent Poster","user_id":146,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"Excipient Selection Strategies to Mitigate Nitrosamine Risks","fancy_title_localized":false,"locale":null,"id":15333,"title":"Excipient Selection Strategies to Mitigate Nitrosamine Risks","slug":"excipient-selection-strategies-to-mitigate-nitrosamine-risks","posts_count":1,"reply_count":0,"highest_post_number":1,"image_url":null,"created_at":"2026-04-08T16:12:58.665Z","last_posted_at":"2026-04-08T16:12:58.749Z","bumped":true,"bumped_at":"2026-04-08T16:12:58.749Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"Excipient Selection Strategies to Mitigate Nitrosamine Risks\nAuthor(s): Joseph Zeleznik, Sydney Badger, Manish Ghimire \nThis is an article from PHARM TECH. \nKey Takeaways\n\nNitrosamines arise via nitrosating agents (nitri…","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":null,"tags":[{"id":2,"name":"Excipients","slug":"excipients"}],"tags_descriptions":{},"views":275,"like_count":5,"has_summary":false,"last_poster_username":"Yosukemino","category_id":16,"op_like_count":5,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":"latest single","description":"Original Poster, Most Recent Poster","user_id":133,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"Excipient Nitrosamine Risk Assessment Tool","fancy_title_localized":false,"locale":null,"id":13604,"title":"Excipient Nitrosamine Risk Assessment Tool","slug":"excipient-nitrosamine-risk-assessment-tool","posts_count":2,"reply_count":0,"highest_post_number":2,"image_url":null,"created_at":"2025-06-30T05:48:56.863Z","last_posted_at":"2026-03-26T13:29:31.909Z","bumped":true,"bumped_at":"2026-03-26T13:29:31.909Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"Qvents has developed an Excipient Nitrosamine Risk Assessment Tool \nIt provides a structured, user-friendly solution that: \n\nGuides you through the IPEC questionnaire\nAutomatically assesses nitrosamine formation risk\nIde…","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":null,"tags":[],"tags_descriptions":{},"views":580,"like_count":2,"has_summary":false,"last_poster_username":"Venki","category_id":16,"op_like_count":2,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":"latest single","description":"Original Poster, Most Recent Poster","user_id":6650,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"Limit Test for NDSRI Risk Assessment?","fancy_title_localized":false,"locale":null,"id":15222,"title":"Limit Test for NDSRI Risk Assessment?","slug":"limit-test-for-ndsri-risk-assessment","posts_count":4,"reply_count":1,"highest_post_number":4,"image_url":null,"created_at":"2026-03-11T16:32:46.986Z","last_posted_at":"2026-03-13T13:17:38.060Z","bumped":true,"bumped_at":"2026-03-13T13:17:38.060Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"I was wondering if a “Limit Test” strategy could theoretically be used to conduct NDSRI risk assessment in drug product to demonstrate that batches do not show any identified potential NDSRIs at or above 10% of the AI li…","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":null,"tags":[],"tags_descriptions":{},"views":283,"like_count":5,"has_summary":false,"last_poster_username":"accarter92","category_id":16,"op_like_count":1,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":"latest","description":"Original Poster, Most Recent Poster","user_id":8120,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":153,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":6537,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"Chat GPT’s answer about the risk assessment of nitrosamine in pharmaceuticals","fancy_title_localized":false,"locale":null,"id":5490,"title":"Chat GPT's answer about the risk assessment of nitrosamine in pharmaceuticals","slug":"chat-gpts-answer-about-the-risk-assessment-of-nitrosamine-in-pharmaceuticals","posts_count":34,"reply_count":12,"highest_post_number":35,"image_url":null,"created_at":"2023-03-12T14:22:55.875Z","last_posted_at":"2026-02-28T18:51:24.867Z","bumped":true,"bumped_at":"2026-02-28T18:51:24.867Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"@Yosukemino : Could you please explain how to perform a risk assessment of nitrosamine impurities in pharmaceuticals? \nChat GPT: Nitrosamine impurities in pharmaceuticals have been a growing concern in recent years due t…","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":null,"tags":[],"tags_descriptions":{},"views":4141,"like_count":58,"has_summary":false,"last_poster_username":"Yosukemino","category_id":16,"op_like_count":4,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":"latest","description":"Original Poster, Most Recent Poster","user_id":133,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":502,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":14,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":1020,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":4,"primary_group_id":null,"flair_group_id":42}]},{"fancy_title":"Nitrosamine Risk Assessment on DETA","fancy_title_localized":false,"locale":null,"id":15163,"title":"Nitrosamine Risk Assessment on DETA","slug":"nitrosamine-risk-assessment-on-deta","posts_count":1,"reply_count":0,"highest_post_number":1,"image_url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/7/765066d161694212b9662bd0d70a1aa8013b8c3c_2_1024x671.jpeg","created_at":"2026-02-22T14:53:04.328Z","last_posted_at":"2026-02-22T14:53:04.401Z","bumped":true,"bumped_at":"2026-02-22T14:53:04.401Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":[{"max_width":null,"max_height":null,"width":1245,"height":816,"url":"https://nitrosamines.usp.org/uploads/db7259/original/2X/7/765066d161694212b9662bd0d70a1aa8013b8c3c.jpeg"},{"max_width":1024,"max_height":1024,"width":1024,"height":671,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/7/765066d161694212b9662bd0d70a1aa8013b8c3c_2_1024x671.jpeg"},{"max_width":750,"max_height":750,"width":750,"height":491,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/7/765066d161694212b9662bd0d70a1aa8013b8c3c_2_750x491.jpeg"},{"max_width":500,"max_height":500,"width":500,"height":327,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/7/765066d161694212b9662bd0d70a1aa8013b8c3c_2_500x327.jpeg"},{"max_width":375,"max_height":375,"width":375,"height":245,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/7/765066d161694212b9662bd0d70a1aa8013b8c3c_2_375x245.jpeg"}],"tags":[],"tags_descriptions":{},"views":187,"like_count":1,"has_summary":false,"last_poster_username":"zifeng.zhu","category_id":16,"op_like_count":1,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":"latest single","description":"Original Poster, Most Recent Poster","user_id":7660,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"Available Tools for Prediction of Potential Degradation Products from Nitrosation Reactions","fancy_title_localized":false,"locale":null,"id":15104,"title":"Available Tools for Prediction of Potential Degradation Products from Nitrosation Reactions","slug":"available-tools-for-prediction-of-potential-degradation-products-from-nitrosation-reactions","posts_count":5,"reply_count":2,"highest_post_number":5,"image_url":null,"created_at":"2026-02-03T20:14:44.430Z","last_posted_at":"2026-02-04T23:59:22.441Z","bumped":true,"bumped_at":"2026-02-04T23:59:22.441Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"Hi Naiffer and everyone in the community, \nI’m looking to learn little bit more about existing tools or approaches that can be used to predict potential degradation products arising from nitrosation reactions for a given…","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":null,"tags":[{"id":12,"name":"NDSRI","slug":"ndsri"},{"id":6,"name":"Drug_Substance_APIs","slug":"drug-substance-apis"},{"id":23,"name":"risk-assessment","slug":"risk-assessment"}],"tags_descriptions":{},"views":348,"like_count":6,"has_summary":false,"last_poster_username":"dineli.ranathunga","category_id":16,"op_like_count":0,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":"latest","description":"Original Poster, Most Recent Poster","user_id":7134,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":6483,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":133,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":3469,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"Nitrosamine Purge Factor Calculation","fancy_title_localized":false,"locale":null,"id":14896,"title":"Nitrosamine Purge Factor Calculation","slug":"nitrosamine-purge-factor-calculation","posts_count":2,"reply_count":0,"highest_post_number":2,"image_url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/3/3f28d2e56c416da6d202ee1f1bd1e369fe2fe9a6_2_1024x576.png","created_at":"2025-12-29T17:31:56.899Z","last_posted_at":"2025-12-30T17:32:04.491Z","bumped":true,"bumped_at":"2025-12-30T17:32:04.491Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"ResolveMass Laboratories Inc. posted an interesting blog. This describes advanced methods for purge calculation during API manufacturing processes. I would like to focus particularly on Chapters 6 and 8. This is truly an…","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":[{"max_width":null,"max_height":null,"width":1280,"height":720,"url":"https://nitrosamines.usp.org/uploads/db7259/original/2X/3/3f28d2e56c416da6d202ee1f1bd1e369fe2fe9a6.png"},{"max_width":1024,"max_height":1024,"width":1024,"height":576,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/3/3f28d2e56c416da6d202ee1f1bd1e369fe2fe9a6_2_1024x576.png"},{"max_width":750,"max_height":750,"width":750,"height":421,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/3/3f28d2e56c416da6d202ee1f1bd1e369fe2fe9a6_2_750x421.png"},{"max_width":500,"max_height":500,"width":500,"height":281,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/3/3f28d2e56c416da6d202ee1f1bd1e369fe2fe9a6_2_500x281.png"},{"max_width":375,"max_height":375,"width":375,"height":210,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/3/3f28d2e56c416da6d202ee1f1bd1e369fe2fe9a6_2_375x210.png"}],"tags":[{"id":6,"name":"Drug_Substance_APIs","slug":"drug-substance-apis"}],"tags_descriptions":{},"views":556,"like_count":9,"has_summary":false,"last_poster_username":"Sagar","category_id":16,"op_like_count":6,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":null,"description":"Original Poster","user_id":133,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":3290,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"The Impact of API Synthesis Optimization on Reducing Nitrosamine Risk: A Technical Walkthrough","fancy_title_localized":false,"locale":null,"id":14862,"title":"The Impact of API Synthesis Optimization on Reducing Nitrosamine Risk: A Technical Walkthrough","slug":"the-impact-of-api-synthesis-optimization-on-reducing-nitrosamine-risk-a-technical-walkthrough","posts_count":1,"reply_count":0,"highest_post_number":1,"image_url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/a/ad0bec0939810156244ed99643b3251304f3057c_2_1024x576.png","created_at":"2025-12-20T20:10:54.457Z","last_posted_at":"2025-12-20T20:10:54.598Z","bumped":true,"bumped_at":"2025-12-20T20:10:54.598Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"ResolveMass Laboratories Inc. posted an interesting blog. This describes effective methods for mitigating nitrosamine risks during API manufacturing processes. \n\n\nSummary\n\nA cross-functional synthesis-to-QC approach ensu…","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":[{"max_width":null,"max_height":null,"width":1280,"height":720,"url":"https://nitrosamines.usp.org/uploads/db7259/original/2X/a/ad0bec0939810156244ed99643b3251304f3057c.png"},{"max_width":1024,"max_height":1024,"width":1024,"height":576,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/a/ad0bec0939810156244ed99643b3251304f3057c_2_1024x576.png"},{"max_width":750,"max_height":750,"width":750,"height":421,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/a/ad0bec0939810156244ed99643b3251304f3057c_2_750x421.png"},{"max_width":500,"max_height":500,"width":500,"height":281,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/a/ad0bec0939810156244ed99643b3251304f3057c_2_500x281.png"},{"max_width":375,"max_height":375,"width":375,"height":210,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/a/ad0bec0939810156244ed99643b3251304f3057c_2_375x210.png"}],"tags":[{"id":23,"name":"risk-assessment","slug":"risk-assessment"}],"tags_descriptions":{},"views":293,"like_count":4,"has_summary":false,"last_poster_username":"Yosukemino","category_id":16,"op_like_count":4,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":"latest single","description":"Original Poster, Most Recent Poster","user_id":133,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":":balance_scale: Risk assessment not strong enough, specifically on related impurities containing secondary amine","fancy_title_localized":false,"locale":null,"id":8902,"title":"⚖️ Risk assessment not strong enough, specifically on related impurities containing secondary amine","slug":"risk-assessment-not-strong-enough-specifically-on-related-impurities-containing-secondary-amine","posts_count":25,"reply_count":14,"highest_post_number":25,"image_url":null,"created_at":"2024-01-15T14:19:08.326Z","last_posted_at":"2025-09-25T10:21:34.889Z","bumped":true,"bumped_at":"2025-09-25T10:21:34.889Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"Hello, have you ever been challenged by any health authorities when submitting a registration file, specifically about secondary amine presents on specified impurity, which would not have been sufficiently assessed, or c…","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":null,"tags":[],"tags_descriptions":{},"views":2555,"like_count":44,"has_summary":false,"last_poster_username":"chrischar","category_id":16,"op_like_count":1,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":null,"description":"Original Poster","user_id":3790,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":4646,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":4,"primary_group_id":null,"flair_group_id":42},{"extras":null,"description":"Recent Poster","user_id":3469,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":4802,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"Stability in risk assessment report","fancy_title_localized":false,"locale":null,"id":14167,"title":"Stability in risk assessment report","slug":"stability-in-risk-assessment-report","posts_count":13,"reply_count":6,"highest_post_number":13,"image_url":null,"created_at":"2025-09-03T07:26:40.979Z","last_posted_at":"2025-09-10T06:06:18.372Z","bumped":true,"bumped_at":"2025-09-10T06:06:18.372Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"hello all, \nduring the preparing of risk assessment report for nitrosamine impurity, what should we say in the stability section, how to make sure that there is no risk during the shelf life of the product? we will not g…","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":null,"tags":[{"id":23,"name":"risk-assessment","slug":"risk-assessment"}],"tags_descriptions":{},"views":784,"like_count":20,"has_summary":false,"last_poster_username":"Yuvraj","category_id":16,"op_like_count":0,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":null,"description":"Original Poster","user_id":6705,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":2485,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":6244,"primary_group_id":63,"flair_group_id":71},{"extras":null,"description":"Recent Poster","user_id":3469,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":1326,"primary_group_id":null,"flair_group_id":71}]},{"fancy_title":"Background on Purging Factor Calculation for your Risk Assessment","fancy_title_localized":false,"locale":null,"id":10758,"title":"Background on Purging Factor Calculation for your Risk Assessment","slug":"background-on-purging-factor-calculation-for-your-risk-assessment","posts_count":8,"reply_count":3,"highest_post_number":8,"image_url":"https://nitrosamines.usp.org/uploads/db7259/original/2X/b/b54f426cb41204f9d843699c8a622eaa4bbfc1a1.png","created_at":"2024-07-25T21:12:48.551Z","last_posted_at":"2025-08-13T01:00:48.453Z","bumped":true,"bumped_at":"2025-08-13T01:00:48.453Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"The name Dr. Andrew Teasdale @AndyT is probably familiar to you in this Nitrosamines space if you are new to it… But Dr. Teasdale’s contribution to the Mutagenic impurity control came earlier as the mastermind of the ‘pu…","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":[{"max_width":null,"max_height":null,"width":829,"height":577,"url":"https://nitrosamines.usp.org/uploads/db7259/original/2X/b/b54f426cb41204f9d843699c8a622eaa4bbfc1a1.png"},{"max_width":750,"max_height":750,"width":750,"height":522,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/b/b54f426cb41204f9d843699c8a622eaa4bbfc1a1_2_750x522.png"},{"max_width":500,"max_height":500,"width":499,"height":348,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/b/b54f426cb41204f9d843699c8a622eaa4bbfc1a1_2_499x348.png"},{"max_width":375,"max_height":375,"width":375,"height":261,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/b/b54f426cb41204f9d843699c8a622eaa4bbfc1a1_2_375x261.png"}],"tags":[{"id":59,"name":"purge","slug":"purge"}],"tags_descriptions":{},"views":2107,"like_count":32,"has_summary":false,"last_poster_username":"fernandaw","category_id":16,"op_like_count":10,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":null,"description":"Original Poster","user_id":4,"primary_group_id":null,"flair_group_id":42},{"extras":null,"description":"Frequent Poster","user_id":4802,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":3469,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":6244,"primary_group_id":63,"flair_group_id":71},{"extras":"latest","description":"Most Recent Poster","user_id":20,"primary_group_id":63,"flair_group_id":63}]},{"fancy_title":"Nitrosamine Risk Mitigation Calculator (by DFE Pharma)","fancy_title_localized":false,"locale":null,"id":13874,"title":"Nitrosamine Risk Mitigation Calculator (by DFE Pharma)","slug":"nitrosamine-risk-mitigation-calculator-by-dfe-pharma","posts_count":2,"reply_count":0,"highest_post_number":2,"image_url":"https://nitrosamines.usp.org/uploads/db7259/original/2X/3/3778f9294e0925e9efe875f9528c29e3bfe462b5.png","created_at":"2025-08-06T21:04:14.723Z","last_posted_at":"2025-08-11T07:02:32.258Z","bumped":true,"bumped_at":"2025-08-11T07:02:32.258Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"DFE Pharma has released an online tool to calculate the risk of nitrosamine contamination. You can easily get calculation results by inputting various information about your tablets into the tool, such as tablet weight, …","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":[{"max_width":null,"max_height":null,"width":557,"height":197,"url":"https://nitrosamines.usp.org/uploads/db7259/original/2X/3/3778f9294e0925e9efe875f9528c29e3bfe462b5.png"},{"max_width":500,"max_height":500,"width":500,"height":176,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/3/3778f9294e0925e9efe875f9528c29e3bfe462b5_2_500x176.png"},{"max_width":375,"max_height":375,"width":375,"height":132,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/3/3778f9294e0925e9efe875f9528c29e3bfe462b5_2_375x132.png"}],"tags":[{"id":12,"name":"NDSRI","slug":"ndsri"},{"id":1,"name":"featured","slug":"featured"}],"tags_descriptions":{},"views":1692,"like_count":14,"has_summary":false,"last_poster_username":"chrischar","category_id":16,"op_like_count":10,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":null,"description":"Original Poster","user_id":133,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":4802,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"Nitrosamines evaluation in transdermal patches","fancy_title_localized":false,"locale":null,"id":9026,"title":"Nitrosamines evaluation in transdermal patches","slug":"nitrosamines-evaluation-in-transdermal-patches","posts_count":13,"reply_count":5,"highest_post_number":13,"image_url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/b/bdf3d9484d9179fd8fc2304c8a0542f0e3d5b75e_2_1024x682.jpeg","created_at":"2024-01-30T19:49:35.759Z","last_posted_at":"2025-07-16T12:33:18.384Z","bumped":true,"bumped_at":"2025-07-16T12:33:18.384Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"Hi all, \nRecently, it got to our attention that several NDSRIs indicated in EMA Appendix 1 theoretically could be in transdermal formulations (i.e., Rotigotine, Lidocaine, Methylphenidate etc.). with NDSRIs in Categor…","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":[{"max_width":null,"max_height":null,"width":1200,"height":800,"url":"https://nitrosamines.usp.org/uploads/db7259/original/2X/b/bdf3d9484d9179fd8fc2304c8a0542f0e3d5b75e.jpeg"},{"max_width":1024,"max_height":1024,"width":1024,"height":682,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/b/bdf3d9484d9179fd8fc2304c8a0542f0e3d5b75e_2_1024x682.jpeg"},{"max_width":750,"max_height":750,"width":750,"height":500,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/b/bdf3d9484d9179fd8fc2304c8a0542f0e3d5b75e_2_750x500.jpeg"},{"max_width":500,"max_height":500,"width":500,"height":333,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/b/bdf3d9484d9179fd8fc2304c8a0542f0e3d5b75e_2_500x333.jpeg"},{"max_width":375,"max_height":375,"width":375,"height":250,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/b/bdf3d9484d9179fd8fc2304c8a0542f0e3d5b75e_2_375x250.jpeg"}],"tags":[],"tags_descriptions":{},"views":2283,"like_count":39,"has_summary":false,"last_poster_username":"ccdw","category_id":16,"op_like_count":6,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":null,"description":"Original Poster","user_id":5080,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":14,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":1243,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":2779,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":3368,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"CMO Nitrosamine Risk Assessment","fancy_title_localized":false,"locale":null,"id":13514,"title":"CMO Nitrosamine Risk Assessment","slug":"cmo-nitrosamine-risk-assessment","posts_count":8,"reply_count":4,"highest_post_number":8,"image_url":null,"created_at":"2025-06-18T17:36:53.106Z","last_posted_at":"2025-06-27T22:13:49.572Z","bumped":true,"bumped_at":"2025-06-27T22:13:49.572Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"Hi My Nitrosators! \nI was told by a CMO that they are no longer going to create and/or revise existing nitrosamine risk assessments for their customers.  They will just keep a copy of a nitrosamine risk assessment that t…","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":null,"tags":[{"id":12,"name":"NDSRI","slug":"ndsri"},{"id":6,"name":"Drug_Substance_APIs","slug":"drug-substance-apis"},{"id":23,"name":"risk-assessment","slug":"risk-assessment"}],"tags_descriptions":{},"views":582,"like_count":6,"has_summary":false,"last_poster_username":"DanitaBroyles","category_id":16,"op_like_count":0,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":"latest","description":"Original Poster, Most Recent Poster","user_id":256,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":4,"primary_group_id":null,"flair_group_id":42},{"extras":null,"description":"Frequent Poster","user_id":2996,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":1020,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":153,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"How to decide if one anticancer drug is for advanced cancer?","fancy_title_localized":false,"locale":null,"id":11422,"title":"How to decide if one anticancer drug is for advanced cancer?","slug":"how-to-decide-if-one-anticancer-drug-is-for-advanced-cancer","posts_count":13,"reply_count":6,"highest_post_number":13,"image_url":null,"created_at":"2024-09-25T03:13:29.974Z","last_posted_at":"2025-06-13T08:59:57.441Z","bumped":true,"bumped_at":"2025-06-13T08:59:57.441Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"Hi to all, according to EMA ‘For finished products intended only for advanced cancer, N-nitrosamine impurities should be controlled according to ICH Q3 A(R2) and ICH Q3B(R2), as specified in the Q&A document to ICH S9.”. …","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":null,"tags":[{"id":23,"name":"risk-assessment","slug":"risk-assessment"}],"tags_descriptions":{},"views":904,"like_count":23,"has_summary":false,"last_poster_username":"paliog","category_id":16,"op_like_count":4,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":null,"description":"Original Poster","user_id":5557,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":2844,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":16,"primary_group_id":45,"flair_group_id":45},{"extras":null,"description":"Recent Poster","user_id":3368,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":2532,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":":open_book: Drug Substance and Drug Product Workflows for Quality Risk Management for the Presence of Nitrosamines in Medicines-Pub","fancy_title_localized":false,"locale":null,"id":13371,"title":"📖 Drug Substance and Drug Product Workflows for Quality Risk Management for the Presence of Nitrosamines in Medicines-Pub","slug":"drug-substance-and-drug-product-workflows-for-quality-risk-management-for-the-presence-of-nitrosamines-in-medicines-pub","posts_count":3,"reply_count":0,"highest_post_number":3,"image_url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/1/1026ebe932b73a835ac099f0fafd0a4c69b43282_2_1024x383.jpeg","created_at":"2025-05-25T08:47:14.804Z","last_posted_at":"2025-05-27T16:00:45.894Z","bumped":true,"bumped_at":"2025-05-27T16:00:45.894Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"Dr. Olivier Dirat et al. presented a paper on the workflow for risk assessment of nitrosamines in medicines. \nhttps://pubs.acs.org/doi/abs/10.1021/acs.oprd.5c00097 \nABSTRACT \nThe ICH M7 guidance “Assessment and Control o…","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":[{"max_width":null,"max_height":null,"width":1250,"height":468,"url":"https://nitrosamines.usp.org/uploads/db7259/original/2X/1/1026ebe932b73a835ac099f0fafd0a4c69b43282.jpeg"},{"max_width":1024,"max_height":1024,"width":1024,"height":383,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/1/1026ebe932b73a835ac099f0fafd0a4c69b43282_2_1024x383.jpeg"},{"max_width":750,"max_height":750,"width":750,"height":280,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/1/1026ebe932b73a835ac099f0fafd0a4c69b43282_2_750x280.jpeg"},{"max_width":500,"max_height":500,"width":500,"height":187,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/1/1026ebe932b73a835ac099f0fafd0a4c69b43282_2_500x187.jpeg"},{"max_width":375,"max_height":375,"width":375,"height":140,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/2X/1/1026ebe932b73a835ac099f0fafd0a4c69b43282_2_375x140.jpeg"}],"tags":[{"id":23,"name":"risk-assessment","slug":"risk-assessment"},{"id":1,"name":"featured","slug":"featured"}],"tags_descriptions":{},"views":1259,"like_count":23,"has_summary":false,"last_poster_username":"Naiffer_Host","category_id":16,"op_like_count":9,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":null,"description":"Original Poster","user_id":133,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":2485,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":4,"primary_group_id":null,"flair_group_id":42}]},{"fancy_title":"Can we bypass confirmatory testing of DP based on Theoretical Calc. of NDSRI’s","fancy_title_localized":false,"locale":null,"id":9088,"title":"Can we bypass confirmatory testing of DP based on Theoretical Calc. of NDSRI's","slug":"can-we-bypass-confirmatory-testing-of-dp-based-on-theoretical-calc-of-ndsris","posts_count":10,"reply_count":3,"highest_post_number":10,"image_url":null,"created_at":"2024-02-05T21:03:04.358Z","last_posted_at":"2025-04-24T15:59:33.703Z","bumped":true,"bumped_at":"2025-04-24T15:59:33.703Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"Hi Guys, \nI have just received Nitrosamine Impurities Risk Assessment report from the API (Diphenhydramine HCl).  The manufacturer has identified the “Risk” and possible formation of NDMA (96.0 ng/day) and N-nitroso-desm…","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":null,"tags":[],"tags_descriptions":{},"views":1589,"like_count":16,"has_summary":false,"last_poster_username":"Naiffer_Host","category_id":16,"op_like_count":0,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":null,"description":"Original Poster","user_id":5107,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":4027,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":52,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":146,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":4,"primary_group_id":null,"flair_group_id":42}]},{"fancy_title":"Nitrosamines in topical products","fancy_title_localized":false,"locale":null,"id":5439,"title":"Nitrosamines in topical products","slug":"nitrosamines-in-topical-products","posts_count":5,"reply_count":1,"highest_post_number":5,"image_url":null,"created_at":"2023-03-07T17:41:40.055Z","last_posted_at":"2025-04-15T11:53:24.616Z","bumped":true,"bumped_at":"2025-04-15T11:53:24.616Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"Dears, \nHave you received requests from authorities to submit nitrosamines risk assessment for topical pharmaceutical products? \nIf yes, what’s the rational of this request? Are there any guidance or related publications…","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":null,"tags":[],"tags_descriptions":{},"views":1357,"like_count":3,"has_summary":false,"last_poster_username":"Bojana","category_id":16,"op_like_count":0,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":null,"description":"Original Poster","user_id":2480,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":1243,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":6634,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"NDSRI in finishe products","fancy_title_localized":false,"locale":null,"id":12744,"title":"NDSRI in finishe products","slug":"ndsri-in-finishe-products","posts_count":3,"reply_count":0,"highest_post_number":3,"image_url":null,"created_at":"2025-03-12T07:46:21.272Z","last_posted_at":"2025-03-13T05:45:37.215Z","bumped":true,"bumped_at":"2025-03-13T05:45:37.215Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"is there any template that could be used in risk assessment report for nitrosamine impurities in finished product? how we can check the conditions of the manufacturing process of FP to exclude the risk of NDSRI formation…","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":null,"tags":[{"id":23,"name":"risk-assessment","slug":"risk-assessment"}],"tags_descriptions":{},"views":472,"like_count":1,"has_summary":false,"last_poster_username":"Hermine4011","category_id":16,"op_like_count":0,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":null,"description":"Original Poster","user_id":6705,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":3469,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":5702,"primary_group_id":null,"flair_group_id":null}]},{"fancy_title":"N-nitrosoamides - a horse of a different color","fancy_title_localized":false,"locale":null,"id":3128,"title":"N-nitrosoamides - a horse of a different color","slug":"n-nitrosoamides-a-horse-of-a-different-color","posts_count":55,"reply_count":34,"highest_post_number":55,"image_url":"https://nitrosamines.usp.org/uploads/db7259/original/1X/8d4307686573ecff0e6c39f9c9fbcce58938a56d.png","created_at":"2022-07-13T21:28:43.839Z","last_posted_at":"2025-03-06T06:45:16.728Z","bumped":true,"bumped_at":"2025-03-06T06:45:16.728Z","archetype":"regular","unseen":false,"pinned":false,"unpinned":null,"excerpt":"Of late, I am seeing an alarming trend where people are mislabeling impurities as nitrosamines, when they are really nitrosamides/carbamates/urea/guanidine. Let us understand thatthe N-nitroso compounds can be divided in…","visible":true,"closed":false,"archived":false,"bookmarked":null,"liked":null,"thumbnails":[{"max_width":null,"max_height":null,"width":625,"height":163,"url":"https://nitrosamines.usp.org/uploads/db7259/original/1X/8d4307686573ecff0e6c39f9c9fbcce58938a56d.png"},{"max_width":500,"max_height":500,"width":500,"height":130,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/1X/8d4307686573ecff0e6c39f9c9fbcce58938a56d_2_500x130.png"},{"max_width":375,"max_height":375,"width":375,"height":97,"url":"https://nitrosamines.usp.org/uploads/db7259/optimized/1X/8d4307686573ecff0e6c39f9c9fbcce58938a56d_2_375x97.png"}],"tags":[{"id":6,"name":"Drug_Substance_APIs","slug":"drug-substance-apis"}],"tags_descriptions":{},"views":8245,"like_count":124,"has_summary":true,"last_poster_username":"chrischar","category_id":16,"op_like_count":11,"pinned_globally":false,"featured_link":null,"has_accepted_answer":false,"can_vote":false,"posters":[{"extras":null,"description":"Original Poster","user_id":14,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":153,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Frequent Poster","user_id":2485,"primary_group_id":null,"flair_group_id":null},{"extras":null,"description":"Recent Poster","user_id":133,"primary_group_id":null,"flair_group_id":null},{"extras":"latest","description":"Most Recent Poster","user_id":4802,"primary_group_id":null,"flair_group_id":null}]}]}}